<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="75374">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01683344</url>
  </required_header>
  <id_info>
    <org_study_id>CE044PIC</org_study_id>
    <nct_id>NCT01683344</nct_id>
  </id_info>
  <brief_title>Clinical and Health Economic Study of PICO in a Community Care Setting</brief_title>
  <official_title>A 100 Patient, Prospective, Randomised, Clinical Evaluation Comparing Clinical and Health Economic Outcomes Between Patients With Chronic or Sub-acute Wounds Treated With Either PICO or Standard Care Dressings</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Smith &amp; Nephew Wound Management Inc</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Smith &amp; Nephew Wound Management Inc</source>
  <oversight_info>
    <authority>United Kingdom: Research Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The current study is being conducted to assess the clinical and cost effectiveness of
      managing patients with a chronic or sub-acute wound in a community setting with PICO and to
      explore the patient experience and issues of concordance that affect patients treated with
      PICO.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Anticipated">March 2013</completion_date>
  <primary_completion_date type="Anticipated">December 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Difference in time to wound closure.</measure>
    <time_frame>Baseline to 12 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>To assess the difference in time to closure for chronic and sub-acute wounds between PICO and standard care.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Difference in reduction in wound area.</measure>
    <time_frame>Baseline to 12 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>To assess the difference in the reduction in wound area for chronic and sub-acute wounds between PICO and standard care.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in reduction in wound depth.</measure>
    <time_frame>Baseline to 12 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>To assess the difference in the reduction in wound depth for chronic and sub-acute wounds between PICO and standard care</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in reduction in wound volume.</measure>
    <time_frame>Baseline to 12 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>To assess the difference in the reduction in wound volume for chronic and sub-acute wounds between PICO and standard care</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in the cost of treatment between PICO and standard care dressings</measure>
    <time_frame>Baseline to 7 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Wounds</condition>
  <arm_group>
    <arm_group_label>PICO NPWT</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>PICO* Single-Use Negative Pressure Wound Therapy (Smith &amp; Nephew Wound Management Inc)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard Care</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Standard of care dressings</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PICO</intervention_name>
    <description>Negative-Pressure Wound Therapy</description>
    <arm_group_label>PICO NPWT</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard Care</intervention_name>
    <description>Standard care dressings</description>
    <arm_group_label>Standard Care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients &gt;18 years old

          -  Males and females. If female, they must not be pregnant or lactating. If female and
             of reproductive age, a pregnancy test will be provided.

          -  The patient or their legal representative (if the patient is incapable of giving
             legal consent), is able to understand the trial and is willing to consent to the
             trial.

          -  Patients with sub-acute or chronic wounds (diabetic foot ulcer, pressure ulcer,
             venous leg ulcer, or other chronic) suitable for treatment with a PICO dressing.

          -  Wound duration ≤52 weeks

          -  Wound area range ≥5 cm2 at start of screening period

          -  Wound maximum linear dimension ≤ 15cm

          -  Able to use English for the interview

        Exclusion Criteria:

          -  Patients with known allergies to product components (silicone adhesives and
             polyurethane films (direct contact with wound), acrylic adhesives (direct contact
             with skin), polyethylene fabrics and super-absorbent powders (polyacrylates) (within
             the dressing).

          -  Wounds which have an infection which is not being treated with systemic antibiotics.

          -  Wounds which are actively bleeding.Exposure of blood vessels, organs, bone or tendon
             at the base of the reference wound

          -  Exclude undermining or tunnelling present or suspected in the wound

          -  Use of negative pressure device on wound in the last 30 days

          -  Malignant wounds/malignancy in the wound

          -  Systemic infection not being treated with systemic antibiotics

          -  Simultaneous treatment with other experimental wound care procedures, biologics or
             devices

          -  Patients with a known history of poor compliance with medical treatment.

          -  Patients who have participated in this trial previously and who closed or were
             withdrawn
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christine Moffatt, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Royal Derby Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kate Drysdale</last_name>
    <phone>+44 1482 673405</phone>
    <email>kate.drysdale@smith-nephew.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Emma Whatley</last_name>
    <phone>+44 1482 673648</phone>
    <email>Emma.Whatley@smith-nephew.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The Royal Derby Hospital</name>
      <address>
        <city>Derby</city>
        <zip>DE22 3NE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>September 2012</verification_date>
  <lastchanged_date>September 11, 2012</lastchanged_date>
  <firstreceived_date>September 7, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>chronic, sub-acute wounds</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
